Is this your brand? Sign in to claim ownership.

UTAK LABORATORIES, INC.

Last updated September 17, 2026

Information

Country: US
Address: 25020 AVENUE TIBBITTS, VALENCIA, CA, 91355
Website: —
LinkedIn: —
Facebook: —
Email: —
Phone: —
PRRC Contact: —
EUDAMED SRN: —
FDA FEI Number: 2022375
DUNS Number: —

Catalogue (1969)

Page 23 of 40

Device	Model / Reference	Registries	Class	Status
Busulfan Level 1 V2	BUS 1 V2 P F EBS UK	FDA UDI	Class I	Active
Benzodiazepines Level 2 V2	BENZO L2 V2 U F UW	FDA UDI	Class I	Active
Busulfan Level 4	BUS C4 MAYO	FDA UDI	Class I	Active
Drugs Of Abuse Level 1	SMX-DAU 1 V2 F PG	FDA UDI	Class I	Active
Immunosuppressants Level 3	IMMU 3 WB WDL	FDA UDI	Class I	Active
Miscellaneous Panel	MP U F LSA	FDA UDI	Class I	Active
Fentanyl Plus Level 2	FENT+ 2 U PM	FDA UDI	Class I	Active
Trace Elements Qc Level 2 V2	TRACE QC 2 V2 S PAML	FDA UDI	Class I	Active
Phenytoin Level 1	PHENY 1 S MCTL	FDA UDI	Class I	Active
Voriconazole Plus Level 3	VORI+ 3 V2 S CMCD	FDA UDI	Class I	Active
Drugs Of Abuse High V2	DAU HIGH V2 F PG	FDA UDI	Class I	Active
Mycophenolic Acid Glucuronide Level 4	MPAG 4 S MAYO	FDA UDI	Class I	Active
Nordiazepam 250 Ng/Ml	NORDIAZ 250 S M	FDA UDI	Class I	Active
Vitamin A Plus E Low	10081	FDA UDI	Class I	Active
Miscellaneous Panel	MP U F SCL	FDA UDI	Class I	Active
Thc Plus Level 6	THC+ 6 U F WCT	FDA UDI	Class I	Active
Creatinine Plus	CREA+ PHAMA	FDA UDI	Class I	Active
Lithium 15 Mmol/L	LIT 15 S F BD	FDA UDI	Class I	Active
Md Labs 43 Drugs High	MD LABS 43 HIGH	FDA UDI	Class I	Active
Busulfan Level 2 V2	BUS 2 V2 P F NIH	FDA UDI	Class I	Active
Barbiturates Plus Low	BARBS+ L S F LC	FDA UDI	Class I	Active
Drugs Of Abuse Level 2	DOA 2 SMX-OF MMC	FDA UDI	Class I	Active
Busulfan Level 1 V2	BUS 1 V2 P F NIH	FDA UDI	Class I	Active
Buprenorphine Hydrolysis Qc	91801 U AL	FDA UDI	Class I	Active
Antid Level 3	ANTID 3 MAYO	FDA UDI	Class I	Active
Codeine-6-B-D-Glucuronide Plus	COD GLUC+ U F DS	FDA UDI	Class I	Active
Md Labs 23 Level 2	MD LABS 23 2 V3 OF	FDA UDI	Class I	Active
Dau Level 1	DAU 1 V2 F SMA	FDA UDI	Class I	Active
Buprenorphine Pos	POS-236-2U	FDA UDI	Class I	Active
Basic Qc	BASIC QC	FDA UDI	Class I	Active
Delta-9-Thc 8 Ng/Ml	DELTA 9 OMEGA	FDA UDI	Class I	Active
Thc Plus Level 5	THC+ 5 U F WCT	FDA UDI	Class I	Active
Antifungal Qc Level 2	ANTIF QC 2 V2 LP F TF	FDA UDI	Class I	Active
Buprenorphine Plus 40 Ng/Ml	BUP+ 40 U PM	FDA UDI	Class I	Active
Drugs Of Abuse Plus Level 4	DA+ 4 WB V4 IMMUN	FDA UDI	Class I	Active
Opiates 500 Ng/Ml	OPIA 500 U	FDA UDI	Class I	Active
Amphetamine Cutoff	AMPH CUT WB NC	FDA UDI	Class I	Active
Vitamin D Plus Low	VIT D+ L S KPRICH	FDA UDI	Class I	Active
Nicotine Urine Level 2	NICOU L2 V2 MAYO	FDA UDI	Class I	Active
Ethanol Bi-Level Set	ETH SET S CRL	FDA UDI	Class I	Active
MMA (Methylmalonic Acid) Level 2	74054	FDA UDI	Class I	Active
Thc Qc	THC QC U F NJSTL	FDA UDI	Class I	Active
Drugs Of Abuse Positive Screen	DAU POS U F PHHC	FDA UDI	Class I	Active
B800daucont2frx0	DAU CONT 2 F RX	FDA UDI	Class I	Active
Daucal1v4f2pttl	DAU CAL 1 V4 F 2PT TL	FDA UDI	Class I	Active
Immunosuppressants Level 1	IMMUN 1 WB F UNC	FDA UDI	Class I	Active
Amphetamine Plus Level 2 V4	AMPH+ 2 U V4 F WBH	FDA UDI	Class I	Active
Hmsb Level 2	HMSB 2 WB F MAYO	FDA UDI	Class I	Active
Thc Plus Level 3	THC+ 3 WB 2PT F LSA	FDA UDI	Class I	Active
Drugs Of Abuse Level 1	DAU QC 1 F MED	FDA UDI	Class I	Active

Related Companies

Authorised Representatives

No authorised representatives on record.

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Recalls (1)

Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.

Date	Recall No.	Class	Status	Reason
Mar 20, 2020	Z-2407-2020	—	terminated	The product has an incorrect reference value for cadmium and an incorrect expected range.